[Anticancer chemotherapy. Prescription in the presence of renal insufficiency].
Moulin
B
B
Centre hospitalier universitaire de Rouen Service de néphrologie, d'hémodialyse et de transplantation, Boisguillaume.
Fillastre
J P
JP
Godin
M
M
Chantrel
F
F
D000477:Alkylating Agents / Q000009:adverse effects / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016207:Cytokines / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000378:metabolism; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000009:adverse effects / Q000627:therapeutic use; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000150:complications* / Q000628:therapy; D059004:Topoisomerase I Inhibitors
D000477:Alkylating Agents; D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D016207:Cytokines; D009607:Nitrosourea Compounds; D059004:Topoisomerase I Inhibitors
Chimiothérapie anticancéreuse. Prescriptions en présence d'une insuffisance rénale.